Vir Biotechnology
VIR
VIR
215 hedge funds and large institutions have $783M invested in Vir Biotechnology in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 75 increasing their positions, 73 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.1% less ownership
Funds ownership: 65.82% → 64.72% (-1.1%)
13% less capital invested
Capital invested by funds: $901M → $783M (-$117M)
Holders
215
Holding in Top 10
2
Calls
$2.65M
Puts
$1.92M
Top Buyers
| 1 | +$15M | |
| 2 | +$7.05M | |
| 3 | +$5.4M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$4.64M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.22M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$17.6M | |
| 3 | -$9.25M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$4.27M |
| 5 |
Barclays
London,
United Kingdom
|
-$4.2M |